Werewolf Therapeutics Inc (HOWL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -60,822 | -70,515 | -37,368 | -53,810 | -49,983 |
| Depreciation Amortization | 1,634 | 1,814 | 1,824 | 1,307 | 216 |
| Accounts receivable | N/A | 1,350 | 5,578 | -6,928 | N/A |
| Accounts payable and accrued liabilities | -7,498 | 3,455 | -4,335 | 3,046 | 1,007 |
| Other Working Capital | -8,205 | 2,526 | -5,894 | 2,539 | 2,277 |
| Other Operating Activity | 14,599 | 5,182 | 7,583 | 13,250 | 3,607 |
| Operating Cash Flow | $-60,292 | $-56,188 | $-32,612 | $-40,596 | $-42,876 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -254 | -769 | -3,611 | -498 |
| Investing Cash Flow | $N/A | $-254 | $-769 | $-3,611 | $-498 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 30,000 | 40,000 | N/A | N/A |
| Debt Repayment | N/A | -40,000 | 0 | N/A | N/A |
| Common Stock Issued | 6,028 | 23,753 | 18,429 | 15,994 | 111,805 |
| Other Financing Activity | 0 | -673 | 0 | -88 | -2,378 |
| Financing Cash Flow | $6,028 | $13,080 | $58,429 | $15,906 | $109,427 |
| Beginning Cash Position | 112,215 | 155,577 | 130,529 | 158,830 | 92,777 |
| End Cash Position | 57,951 | 112,215 | 155,577 | 130,529 | 158,830 |
| Net Cash Flow | $-54,264 | $-43,362 | $25,048 | $-28,301 | $66,053 |
| Free Cash Flow | |||||
| Operating Cash Flow | -60,292 | -56,188 | -32,612 | -40,596 | -42,876 |
| Capital Expenditure | N/A | -254 | -769 | -3,611 | -498 |
| Free Cash Flow | -60,292 | -56,442 | -33,381 | -44,207 | -43,374 |